Crossmark

Low rate of adverse events in a randomized controlled trial addressing the surgical treatment of femoroacetabular impingement (FAI) syndrome

Crossref DOI link: https://doi.org/10.1007/s00167-020-06236-6

Published Online: 2020-09-02

Published Print: 2021-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ohlin, Axel

Simunovic, Nicole

Duong, Andrew

Ayeni, Olufemi R. https://orcid.org/0000-0003-4219-8564
Funding

Funding for this research was provided by:

Canadian Institutes of Health Research

Canadian Orthopaedic Foundation

Hamilton Health Sciences

Canadian Institutes of Health Research

American Orthopaedic Society for Sports Medicine

Canadian Orthopaedic Foundation

McMaster Surgical Associates

Hamilton Health Sciences
License Information

Version of Record valid from 2020-09-02

Text and Data Mining valid from 2020-09-02

Version of Record valid from 2020-09-02
More Information

Article History

Received: 23 July 2020

Accepted: 10 August 2020

First Online: 2 September 2020

Compliance with ethical standards

:

: The authors declared that they have no conflict of interest.

: Ethics approval was granted by the Hamilton Integrated Research Ethics Board #12-396.

: Informed consent was provided by all patients in the study.